The MOGE(S) classification of cardiomyopathy for clinicians

Journal of the American College of Cardiology

Volumn 64, Issue 3, 2014, Pages 304-318

  Arbustini, Eloisa ^a   Narula, Navneet ^b   Tavazzi, Luigi ^c   Serio, Alessandra ^a   Grasso, Maurizia ^a   Favalli, Valentina ^a   Bellazzi, Riccardo ^d   Tajik, Jamil A ^e   Bonow, Robert D ^f   Fuster, Valentin ^g   Narula, Jagat ^g  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MARIA CECILIA HOSPITAL   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e ST LUKE S MEDICAL CENTER   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

cardiomyopathy; classification; genetics

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CLINICAL PRACTICE; DISEASE CLASSIFICATION; FUNCTIONAL STATUS; GENE MUTATION; HUMAN; INHERITANCE; MEDICAL SOCIETY; MORPHOFUNCTIONAL PHENOTYPE ORGAN INVOLVEMENT GENETIC INHERITANCE PATTERN ETIOLOGICAL ANNOTATION FUNCTIONAL STATUS CLASSIFICATION; NEW YORK HEART ASSOCIATION CLASS; PHENOTYPE; PRIORITY JOURNAL; STANDARDIZATION; CAUSAL ATTRIBUTION; GENETIC ASSOCIATION; HEALTH CARE PERSONNEL; MEDICAL TERMINOLOGY; PATHOLOGICAL ANATOMY;

CARDIOMYOPATHY; CLASSIFICATION; GENETICS;

CARDIOLOGY; CARDIOMYOPATHIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; PHYSICIANS;

EID: 84904553187     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.05.027     Document Type: Review

References (77)

1. B.J. Maron, J.A. Towbin, and G. Thiene et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
2. P. Elliott, B. Andersson, and E. Arbustini et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 2008 270 276
3. United Healthcare. Available at: http://www.acc.org/clinical/statements. html. Accessed June 5, 2014.
4. M.K. Baig, J.H. Goldman, and A.L. Caforio et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease J Am Coll Cardiol 31 1998 195 201
5. A. Gavazzi, A. Repetto, and L. Scelsi et al. Evidence-based diagnosis of familial non-X-linked dilated cardiomyopathy. Prevalence, inheritance and characteristics Eur Heart J 22 2001 73 81
6. R.T. Murphy, R. Thaman, and J.G. Blanes et al. Natural history and familial characteristics of isolated left ventricular non-compaction Eur Heart J 26 2005 187 192
7. N.G. Mahon, R.T. Murphy, and C.A. MacRae et al. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease Ann Intern Med 143 2005 108 115
8. W.J. McKenna, P. Spirito, and M. Desnos et al. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families Heart 77 1997 130 132
9. A. Nava, B. Bauce, and C. Basso et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy J Am Coll Cardiol 36 2000 2226 2233
10. M.S. Hamid, M. Norman, and A. Quraishi et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria J Am Coll Cardiol 40 2002 1445 1450
11. A.L. Caforio, S. Pankuweit, E. Arbustini European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 34 2013 2636 2648 2648a-2648d
12. D. Jacoby, and W.J. McKenna Genetics of inherited cardiomyopathy Eur Heart J 33 2012 296 304
13. H. Watkins, H. Ashrafian, and C. Redwood Inherited cardiomyopathies N Engl J Med 364 2011 1643 1656
14. B.J. Maron, M.S. Maron, and C. Semsarian Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives J Am Coll Cardiol 60 2012 705 715
15. L.R. Lopes, M.S. Rahman, and P.M. Elliott A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations Heart 99 2013 1800 1811
16. P. Charron, M. Arad, and E. Arbustini et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 3 2010 2715 2726
17. C. Rapezzi, E. Arbustini, and A.P.L. Caforio et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases Eur Heart J 34 2013 1448 1458
18. T.D. Karamitsos, and S. Neubauer The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies Curr Cardiol Rep 15 2013 326
19. G. Quarta, D.M. Sado, and J.C. Moon Cardiomyopathies: focus on cardiovascular magnetic resonance Br J Radiol 84 2011 S296 S305
20. E. Arbustini, M. Pasotti, and A. Pilotto et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects Eur J Heart Fail 8 2006 477 483
21. E. Arbustini, F. Cecchi, O. Dubourg Myocardial and Pericardial Working Group of the European Society of Cardiology The need for European Registries in inherited cardiomyopathies Eur Heart J 23 2002 1972 1974
22. N. Norton, D. Li, E. Rampersaud National Heart, Lung, and Blood Institute GO Exome Sequencing Project and the Exome Sequencing Project Family Studies Project Team Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy Circ Cardiovasc Genet 6 2013 144 153
23. R.E. Hershberger, and J.D. Siegfried Update 2011: clinical and genetic issues in familial dilated cardiomyopathy J Am Coll Cardiol 57 2011 1641 1649
24. J.A. Jarcho, W. McKenna, and J.A. Pare et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1 N Engl J Med 321 1989 1372 1378
25. B. Meder, F. Rühle, and T. Weis et al. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy Eur Heart J 35 2014 1069 1077
26. E. Villard, C. Perret, and F. Gary et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy Eur Heart J 32 2011 1065 1076
27. R.E. Hershberger, D.J. Hedges, and A. Morales Dilated cardiomyopathy: the complexity of a diverse genetic architecture Nature Rev Cardiol 10 2013 531
28. J. Romero, E. Mejia-Lopez, and C. Manrique et al. Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): a systematic literature review Clin Med Insights Cardiol 7 2013 97 114
29. J. Mogensen, and E. Arbustini Restrictive cardiomyopathy Curr Opin Cardiol 24 2009 214 220
30. M. Merlo, G. Sinagra, and E. Carniel et al. Sarcomeric gene causing DCM: poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy Clin Transl Sci 6 2013 424 428
31. M. Zhang, F. Tavora, and A. Burke Desmosomal protein gene mutations in patients with idiopathic DCM Heart 97 2011 2090
32. G. Quarta, P. Syrris, and M. Ashworth et al. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy Eur Heart J 33 2012 1128 1136
33. F.W. Friedrich, B.R. Wilding, and S. Reischmann et al. Non sarcomeric genes cause HCM: evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy Hum Mol Genet 21 2012 3237 3254
34. F. Girolami, C.Y. Ho, and C. Semsarian et al. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations J Am Coll Cardiol 55 2010 1444 1453
35. L.R. Lopes, and P.M. Elliott New approaches to the clinical diagnosis of inherited heart muscle disease Heart 99 2013 1451 1461
36. A.C. Sturm Genetic testing in the contemporary diagnosis of cardiomyopathy Curr Heart Fail Rep 10 2013 63 72
37. A. Morales, and R.E. Hershberger Genetic evaluation of dilated cardiomyopathy Curr Cardiol Rep 15 2013 375
38. K.S. Frese, H.A. Katus, and B. Meder Next-generation sequencing: from understanding biology to personalized medicine Biology 2 2013 378 398
39. D. Corrado, C. Basso, and G. Thiene Is it time to include ion channel diseases among cardiomyopathies? J Electrocardiol 38 Suppl 4 2005 81 87
40. S. Pankuweit, A. Richter, and V. Ruppert et al. Classification of cardiomyopathies and indication for endomyocardial biopsy revisited Herz 34 2009 55 62
41. G. Webster, and C.I. Berul An update on channelopathies: from mechanisms to management Circulation 127 2013 126 140
42. M. Diegoli, M. Grasso, and V. Favalli et al. Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects J Am Coll Cardiol 58 2011 925 934
43. M. Pasotti, C. Klersy, and A. Pilotto et al. Long-term outcome and risk stratification in dilated cardiolaminopathies J Am Coll Cardiol 52 2008 1250 1260
44. K.G. Claeys, P.F. van der Ven, and A. Behin et al. Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study Acta Neuropathol 117 2009 293 307
45. P. von Nandelstadh, R. Soliymani, and M. Baumann et al. Analysis of myotilin turnover provides mechanistic insight into the role of myotilinopathy-causing mutations Biochem J 436 2011 113 121
46. A. Ferlini, M. Neri, and F. Gualandi The medical genetics of dystrophinopathies: molecular genetic diagnosis and its impact on clinical practice Neuromuscul Disord 23 2013 4
47. C.S. Clemen, H. Herrmann, and S.V. Strelkov et al. Desminopathies: pathology and mechanisms Acta Neuropathol 125 2013 47 75
48. C. Bruno, F. Sotgia, and E. Gazzerro et al. Caveolinopathies R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, M.P. Adam, GeneReviews. [Internet] 2012 University of Washington Seattle Seattle, WA
49. H.P. Lo, S.T. Cooper, and F.J. Evesson et al. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis Neuromuscul Disord 18 2008 34 44
50. F. Ceravolo, S. Messina, and C. Rodolico et al. D. Myoglobinuria as first clinical sign of a primary alpha-sarcoglycanopathy Eur J Pediatr 173 2014 239 242
51. M.C. Walter, P. Reilich, and S. Thiele et al. Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial Orphanet J Rare Dis 8 2013 26
52. E.P. Hoffman, and P.R. Clemens HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathies Curr Opin Rheumatol 8 1996 528 538
53. M.S. Wehnert, and G. Bonne The nuclear muscular dystrophies Semin Pediatr Neurol 9 2002 100 107
54. E. Arbustini, N. Narula, and W.G. Dec et al. The MOGE(S) Classification for a phenotype-genotype nomenclature of cardiomyopathy. Endorsed by the World Heart Federation J Am Coll Cardiol 62 2013 2046 2072
55. E. Arbustini, N. Narula, and W.G. Dec et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy. endorsed by the World Heart Federation G Heart 8 2013 355 382
56. L.H. Sobin, M.K. Gospodarowicz, and Ch. Wittekind TNM Classification of Malignant Tumors 7th edition 2009 Wiley-Blackwell Oxford
57. Human Genome Variation Society. Available at: http://www.hgvs.org/ mutnomen/. Accessed June 5, 2014.
58. I.A. Adzhubei, S. Schmidt, and L. Peshkin et al. A method and server for predicting damaging missense mutations Nat Methods 7 2010 248 249
59. P. Kumar, S. Henikoff, and P.C. Ng Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm Nat Protoc 4 2009 1073 1081
60. National Heart, Lung, and Blood Institute. Exome Sequencing Project. Hosted by the University of Washington. Available at: http://evs.gs.washington. edu/EVS/. Accessed June 5, 2014.
61. 1,000 Genome Project. Available at: http://www.1000genomes.org/about. Accessed June 5, 2014.
62. Universal Mutation Database. Available at: http://www.umd.be/HSF/. Accessed June 5, 2014.
63. MOGES. Available at: http://moges.biomeris.com/. Accessed June 5, 2014.
64. E. Arbustini, N. Narula, and G.W. Dec et al. MOGE(S) nosology in low-to-middle-income countries Nat Rev Cardiol 11 2014 307
65. C. Brodt, J.D. Siegfried, and M. Hofmeyer et al. Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy J Card Fail 19 2013 233 239
66. P.M. Elliott Classification of cardiomyopathies: evolution or revolution? J Am Coll Cardiol 62 2013 2073 2074
67. B.M. Mayosi Cardiomyopathies: MOGE(S): a standardized classification of cardiomyopathies? Nat Rev Cardiol 11 2014 134 135
68. F.I. Marcus, W.J. McKenna, and D. Sherrill et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria Eur Heart J 31 2010 806 814
69. E. Arbustini, N. Narula, and W.G. Dec et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers? (letter) J Am Coll Cardiol 63 2014 2584 2586
70. K. Sliwa, and A.O. Mocumbi Forgotten cardiovascular diseases in Africa Clin Res Cardiol 99 2010 65 74
71. M.A. Blankerhorn, and E.A. Gall Myocarditis and myocardosis: a clinicopathologic appraisal Circulation 13 1956 217 223
72. W. Bridgen Uncommon myocardial diseases: the non-coronary cardiomyopathies Lancet 273 1957 1179 1184
73. J.F. Goodwin, and C.M. Oakley The cardiomyopathies Br Heart J 34 1972 545 552
74. Report of the WHO/ISFC Task Force on the definition and classification of cardiomyopathies Br Heart J 44 1980 672 673
75. P. Richardson, W. McKenna, and M. Bristow et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies Circulation 93 1996 841 842
76. R.E. Hershberger, J. Lindenfeld, L. Mestroni, C.E. Seidman, M.R. Taylor, and J.A. Towbin et al. Heart Failure Society of America. Genetic evaluation of cardiomyopathy - a Heart Failure Society of America practice guideline J Cardiol Fail 15 2009 83 97
77. M.J. Ackerman, S.G. Priori, and S. Willems et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Europace 13 2011 1077 1109